nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—vein—colon cancer	0.0461	0.127	CbGeAlD
L-Arginine—NOS3—umbilical vein—colon cancer	0.0334	0.0925	CbGeAlD
L-Arginine—ASL—renal system—colon cancer	0.0168	0.0466	CbGeAlD
L-Arginine—NOS3—endothelium—colon cancer	0.0158	0.0438	CbGeAlD
L-Arginine—NOS3—blood vessel—colon cancer	0.0146	0.0404	CbGeAlD
L-Arginine—ASL—digestive system—colon cancer	0.0138	0.0382	CbGeAlD
L-Arginine—AZIN2—vagina—colon cancer	0.0131	0.0363	CbGeAlD
L-Arginine—SLC7A1—renal system—colon cancer	0.011	0.0305	CbGeAlD
L-Arginine—ASL—liver—colon cancer	0.0103	0.0285	CbGeAlD
L-Arginine—ARG2—epithelium—colon cancer	0.0102	0.0282	CbGeAlD
L-Arginine—ARG2—renal system—colon cancer	0.00944	0.0261	CbGeAlD
L-Arginine—SLC7A1—digestive system—colon cancer	0.00906	0.0251	CbGeAlD
L-Arginine—AZIN2—lymph node—colon cancer	0.00849	0.0235	CbGeAlD
L-Arginine—ASL—lymph node—colon cancer	0.00789	0.0218	CbGeAlD
L-Arginine—ASS1—epithelium—colon cancer	0.00714	0.0197	CbGeAlD
L-Arginine—NOS3—epithelium—colon cancer	0.00711	0.0197	CbGeAlD
L-Arginine—ASS1—smooth muscle tissue—colon cancer	0.00688	0.019	CbGeAlD
L-Arginine—NOS3—smooth muscle tissue—colon cancer	0.00685	0.019	CbGeAlD
L-Arginine—ARG2—vagina—colon cancer	0.00684	0.0189	CbGeAlD
L-Arginine—ASS1—renal system—colon cancer	0.00662	0.0183	CbGeAlD
L-Arginine—NOS3—renal system—colon cancer	0.0066	0.0183	CbGeAlD
L-Arginine—Rash macular—Capecitabine—colon cancer	0.00618	0.045	CcSEcCtD
L-Arginine—NOS3—lymphoid tissue—colon cancer	0.00548	0.0152	CbGeAlD
L-Arginine—ASS1—digestive system—colon cancer	0.00543	0.015	CbGeAlD
L-Arginine—NOS3—digestive system—colon cancer	0.00541	0.015	CbGeAlD
L-Arginine—Paraesthesia oral—Capecitabine—colon cancer	0.00541	0.0394	CcSEcCtD
L-Arginine—Skin necrosis—Methotrexate—colon cancer	0.0054	0.0394	CcSEcCtD
L-Arginine—SLC7A1—lymph node—colon cancer	0.00517	0.0143	CbGeAlD
L-Arginine—SLC16A10—epithelium—colon cancer	0.0051	0.0141	CbGeAlD
L-Arginine—ASS1—vagina—colon cancer	0.00479	0.0133	CbGeAlD
L-Arginine—NOS3—vagina—colon cancer	0.00478	0.0132	CbGeAlD
L-Arginine—Numbness—Vincristine—colon cancer	0.00469	0.0342	CcSEcCtD
L-Arginine—Necrosis—Fluorouracil—colon cancer	0.00462	0.0337	CcSEcCtD
L-Arginine—Sensory loss—Vincristine—colon cancer	0.00449	0.0327	CcSEcCtD
L-Arginine—Extravasation—Vincristine—colon cancer	0.00446	0.0325	CcSEcCtD
L-Arginine—ARG2—lymph node—colon cancer	0.00442	0.0122	CbGeAlD
L-Arginine—Numbness—Fluorouracil—colon cancer	0.00438	0.0319	CcSEcCtD
L-Arginine—Extravasation—Irinotecan—colon cancer	0.00434	0.0316	CcSEcCtD
L-Arginine—Platelet count decreased—Capecitabine—colon cancer	0.00426	0.0311	CcSEcCtD
L-Arginine—SLC22A4—renal system—colon cancer	0.00421	0.0117	CbGeAlD
L-Arginine—Sensory loss—Fluorouracil—colon cancer	0.00419	0.0305	CcSEcCtD
L-Arginine—Extravasation—Fluorouracil—colon cancer	0.00416	0.0303	CcSEcCtD
L-Arginine—ASS1—liver—colon cancer	0.00404	0.0112	CbGeAlD
L-Arginine—NOS3—liver—colon cancer	0.00403	0.0112	CbGeAlD
L-Arginine—SLC16A10—lymphoid tissue—colon cancer	0.00393	0.0109	CbGeAlD
L-Arginine—SLC22A4—digestive system—colon cancer	0.00345	0.00956	CbGeAlD
L-Arginine—SLC16A10—vagina—colon cancer	0.00342	0.00948	CbGeAlD
L-Arginine—SLC22A4—bone marrow—colon cancer	0.00318	0.00881	CbGeAlD
L-Arginine—ASS1—lymph node—colon cancer	0.0031	0.00858	CbGeAlD
L-Arginine—NOS3—lymph node—colon cancer	0.00309	0.00855	CbGeAlD
L-Arginine—SLC22A4—vagina—colon cancer	0.00305	0.00844	CbGeAlD
L-Arginine—Swelling—Fluorouracil—colon cancer	0.00299	0.0218	CcSEcCtD
L-Arginine—SLC16A10—liver—colon cancer	0.00289	0.00799	CbGeAlD
L-Arginine—SLC22A5—renal system—colon cancer	0.00279	0.00771	CbGeAlD
L-Arginine—Lethargy—Fluorouracil—colon cancer	0.00269	0.0196	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—TOP1—colon cancer	0.00266	0.00531	CbGpPWpGaD
L-Arginine—Injection site reaction—Capecitabine—colon cancer	0.00252	0.0184	CcSEcCtD
L-Arginine—NOS3—eNOS activation—AKT1—colon cancer	0.00244	0.00487	CbGpPWpGaD
L-Arginine—Skin exfoliation—Capecitabine—colon cancer	0.00242	0.0176	CcSEcCtD
L-Arginine—NOS2—IL12-mediated signaling events—CD8A—colon cancer	0.00241	0.0048	CbGpPWpGaD
L-Arginine—Necrosis—Methotrexate—colon cancer	0.0024	0.0175	CcSEcCtD
L-Arginine—AZIN2—Metabolism—ODC1—colon cancer	0.00237	0.00474	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CHST5—colon cancer	0.00237	0.00474	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.00232	0.00464	CbGpPWpGaD
L-Arginine—SLC22A5—digestive system—colon cancer	0.00229	0.00632	CbGeAlD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—SRC—colon cancer	0.00224	0.00446	CbGpPWpGaD
L-Arginine—SLC16A10—lymph node—colon cancer	0.00222	0.00613	CbGeAlD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—colon cancer	0.00218	0.00435	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	0.00218	0.00434	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—BAX—colon cancer	0.00217	0.00433	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ODC1—colon cancer	0.00217	0.00433	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CHST5—colon cancer	0.00217	0.00433	CbGpPWpGaD
L-Arginine—Extravasation—Methotrexate—colon cancer	0.00216	0.0158	CcSEcCtD
L-Arginine—NOS3—ACE Inhibitor Pathway—TGFB1—colon cancer	0.00211	0.00422	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—colon cancer	0.00211	0.00421	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—BCL2L1—colon cancer	0.00209	0.00416	CbGpPWpGaD
L-Arginine—Swelling—Capecitabine—colon cancer	0.00209	0.0152	CcSEcCtD
L-Arginine—Sweating—Vincristine—colon cancer	0.00209	0.0152	CcSEcCtD
L-Arginine—ASS1—Metabolism—CA7—colon cancer	0.00206	0.00411	CbGpPWpGaD
L-Arginine—Sweating—Irinotecan—colon cancer	0.00203	0.0148	CcSEcCtD
L-Arginine—SLC22A5—vagina—colon cancer	0.00202	0.00558	CbGeAlD
L-Arginine—SLC22A4—lymph node—colon cancer	0.00197	0.00546	CbGeAlD
L-Arginine—Hypoaesthesia—Vincristine—colon cancer	0.00194	0.0142	CcSEcCtD
L-Arginine—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—colon cancer	0.00194	0.00387	CbGpPWpGaD
L-Arginine—Lethargy—Capecitabine—colon cancer	0.00188	0.0137	CcSEcCtD
L-Arginine—Hypoaesthesia—Fluorouracil—colon cancer	0.00181	0.0132	CcSEcCtD
L-Arginine—Skin exfoliation—Methotrexate—colon cancer	0.0018	0.0131	CcSEcCtD
L-Arginine—ARG2—Metabolism—CHST5—colon cancer	0.0018	0.00359	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ODC1—colon cancer	0.0018	0.00359	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—SRC—colon cancer	0.00179	0.00358	CbGpPWpGaD
L-Arginine—Flushing—Irinotecan—colon cancer	0.00177	0.0129	CcSEcCtD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—CTNNB1—colon cancer	0.00175	0.0035	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—VEGFA—colon cancer	0.00175	0.00349	CbGpPWpGaD
L-Arginine—SLC22A5—liver—colon cancer	0.0017	0.00471	CbGeAlD
L-Arginine—NOS3—Leptin signaling pathway—BAX—colon cancer	0.00154	0.00307	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—colon cancer	0.0015	0.003	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—colon cancer	0.00142	0.00283	CbGpPWpGaD
L-Arginine—Lethargy—Methotrexate—colon cancer	0.0014	0.0102	CcSEcCtD
L-Arginine—Anaphylactic shock—Vincristine—colon cancer	0.00139	0.0101	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—PIK3CA—colon cancer	0.00136	0.00272	CbGpPWpGaD
L-Arginine—Haematuria—Capecitabine—colon cancer	0.00135	0.00985	CcSEcCtD
L-Arginine—Anaphylactic shock—Irinotecan—colon cancer	0.00135	0.00985	CcSEcCtD
L-Arginine—NOS3—Metabolism of nitric oxide—AKT1—colon cancer	0.00134	0.00268	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Vincristine—colon cancer	0.00134	0.00977	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—BCL2L1—colon cancer	0.00134	0.00267	CbGpPWpGaD
L-Arginine—Anorexia—Vincristine—colon cancer	0.00132	0.00964	CcSEcCtD
L-Arginine—Hyperhidrosis—Irinotecan—colon cancer	0.00131	0.00952	CcSEcCtD
L-Arginine—SLC22A5—lymph node—colon cancer	0.00131	0.00361	CbGeAlD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—colon cancer	0.00131	0.0026	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Fluorouracil—colon cancer	0.00129	0.00943	CcSEcCtD
L-Arginine—Anorexia—Irinotecan—colon cancer	0.00129	0.00939	CcSEcCtD
L-Arginine—Hypoaesthesia—Capecitabine—colon cancer	0.00127	0.00923	CcSEcCtD
L-Arginine—Tachycardia—Fluorouracil—colon cancer	0.00126	0.0092	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.00126	0.00251	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CCND1—colon cancer	0.00126	0.00251	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ODC1—colon cancer	0.00125	0.00249	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CHST5—colon cancer	0.00125	0.00249	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—PIK3CA—colon cancer	0.00124	0.00248	CbGpPWpGaD
L-Arginine—Anorexia—Fluorouracil—colon cancer	0.00123	0.00899	CcSEcCtD
L-Arginine—Decreased appetite—Vincristine—colon cancer	0.00121	0.00879	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—colon cancer	0.00119	0.00238	CbGpPWpGaD
L-Arginine—Flushing—Capecitabine—colon cancer	0.00118	0.00861	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—CASP3—colon cancer	0.00118	0.00236	CbGpPWpGaD
L-Arginine—Decreased appetite—Irinotecan—colon cancer	0.00117	0.00856	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—PIK3CA—colon cancer	0.00117	0.00234	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—SRC—colon cancer	0.00117	0.00233	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—EP300—colon cancer	0.00116	0.00231	CbGpPWpGaD
L-Arginine—Decreased appetite—Fluorouracil—colon cancer	0.00113	0.0082	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	0.00112	0.00224	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—colon cancer	0.00112	0.00224	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—AKT1—colon cancer	0.00112	0.00222	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—colon cancer	0.00108	0.00215	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—EP300—colon cancer	0.00106	0.00211	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—SRC—colon cancer	0.00103	0.00205	CbGpPWpGaD
L-Arginine—Hypersensitivity—Vincristine—colon cancer	0.00102	0.00745	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—SRC—colon cancer	0.00102	0.00203	CbGpPWpGaD
L-Arginine—Sweating—Methotrexate—colon cancer	0.00101	0.00737	CcSEcCtD
L-Arginine—Haematuria—Methotrexate—colon cancer	0.00101	0.00733	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.001	0.002	CbGpPWpGaD
L-Arginine—Hypersensitivity—Irinotecan—colon cancer	0.000996	0.00725	CcSEcCtD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—AKT1—colon cancer	0.000986	0.00197	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—colon cancer	0.000978	0.00195	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	0.000968	0.00193	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—AKT1—colon cancer	0.000958	0.00191	CbGpPWpGaD
L-Arginine—Hypersensitivity—Fluorouracil—colon cancer	0.000954	0.00695	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—BRAF—colon cancer	0.000937	0.00187	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TYMS—colon cancer	0.000936	0.00187	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—CASP3—colon cancer	0.000917	0.00183	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—SRC—colon cancer	0.000911	0.00182	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—colon cancer	0.000911	0.00182	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—EGFR—colon cancer	0.000902	0.0018	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CA7—colon cancer	0.000896	0.00179	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—colon cancer	0.000891	0.00178	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	0.000889	0.00177	CbGpPWpGaD
L-Arginine—Tachycardia—Capecitabine—colon cancer	0.000883	0.00643	CcSEcCtD
L-Arginine—Vomiting—Vincristine—colon cancer	0.000882	0.00643	CcSEcCtD
L-Arginine—Rash—Vincristine—colon cancer	0.000875	0.00638	CcSEcCtD
L-Arginine—Hyperhidrosis—Capecitabine—colon cancer	0.000874	0.00637	CcSEcCtD
L-Arginine—Dermatitis—Vincristine—colon cancer	0.000874	0.00637	CcSEcCtD
L-Arginine—Headache—Vincristine—colon cancer	0.000869	0.00633	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—colon cancer	0.000863	0.00172	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—colon cancer	0.000863	0.00172	CbGpPWpGaD
L-Arginine—Anorexia—Capecitabine—colon cancer	0.000862	0.00628	CcSEcCtD
L-Arginine—Vomiting—Irinotecan—colon cancer	0.000859	0.00626	CcSEcCtD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—PIK3CA—colon cancer	0.000856	0.00171	CbGpPWpGaD
L-Arginine—Rash—Irinotecan—colon cancer	0.000852	0.00621	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NRAS—colon cancer	0.000852	0.0017	CbGpPWpGaD
L-Arginine—Dermatitis—Irinotecan—colon cancer	0.000851	0.0062	CcSEcCtD
L-Arginine—Headache—Irinotecan—colon cancer	0.000847	0.00617	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—colon cancer	0.000842	0.00168	CbGpPWpGaD
L-Arginine—NOS2—Disease—LGR5—colon cancer	0.000835	0.00166	CbGpPWpGaD
L-Arginine—NOS2—Disease—CHST5—colon cancer	0.000835	0.00166	CbGpPWpGaD
L-Arginine—Nausea—Vincristine—colon cancer	0.000824	0.00601	CcSEcCtD
L-Arginine—Vomiting—Fluorouracil—colon cancer	0.000823	0.006	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	0.000823	0.00164	CbGpPWpGaD
L-Arginine—Rash—Fluorouracil—colon cancer	0.000816	0.00595	CcSEcCtD
L-Arginine—Dermatitis—Fluorouracil—colon cancer	0.000815	0.00594	CcSEcCtD
L-Arginine—Headache—Fluorouracil—colon cancer	0.000811	0.00591	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—colon cancer	0.000806	0.00161	CbGpPWpGaD
L-Arginine—Nausea—Irinotecan—colon cancer	0.000803	0.00585	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—colon cancer	0.000799	0.00159	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—SRC—colon cancer	0.000799	0.00159	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—colon cancer	0.000798	0.00159	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000789	0.00157	CbGpPWpGaD
L-Arginine—Decreased appetite—Capecitabine—colon cancer	0.000786	0.00573	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—SRC—colon cancer	0.00078	0.00156	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—colon cancer	0.000776	0.00155	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—colon cancer	0.000773	0.00154	CbGpPWpGaD
L-Arginine—Nausea—Fluorouracil—colon cancer	0.000769	0.0056	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—colon cancer	0.00076	0.00152	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—colon cancer	0.000759	0.00151	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—colon cancer	0.000748	0.00149	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CASP3—colon cancer	0.000742	0.00148	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000734	0.00146	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—colon cancer	0.000733	0.00146	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.000726	0.00145	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—colon cancer	0.000722	0.00144	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—SRC—colon cancer	0.000721	0.00144	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—colon cancer	0.000715	0.00143	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CASP3—colon cancer	0.000703	0.0014	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—colon cancer	0.0007	0.0014	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CTNNB1—colon cancer	0.000678	0.00135	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—PIK3CA—colon cancer	0.000674	0.00134	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Methotrexate—colon cancer	0.000673	0.00491	CcSEcCtD
L-Arginine—Hypersensitivity—Capecitabine—colon cancer	0.000666	0.00486	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—PPARG—colon cancer	0.000663	0.00132	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Methotrexate—colon cancer	0.000651	0.00474	CcSEcCtD
L-Arginine—NOS3—Disease—LGR5—colon cancer	0.000648	0.00129	CbGpPWpGaD
L-Arginine—NOS3—Disease—CHST5—colon cancer	0.000648	0.00129	CbGpPWpGaD
L-Arginine—Anorexia—Methotrexate—colon cancer	0.000642	0.00468	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000639	0.00128	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—AKT1—colon cancer	0.000639	0.00128	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—colon cancer	0.000632	0.00126	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ABCB1—colon cancer	0.000627	0.00125	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—colon cancer	0.000623	0.00124	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—colon cancer	0.00062	0.00124	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—TYMS—colon cancer	0.000616	0.00123	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—CTNNB1—colon cancer	0.0006	0.0012	CbGpPWpGaD
L-Arginine—NOS2—Disease—AXIN2—colon cancer	0.0006	0.0012	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—BRAF—colon cancer	0.000596	0.00119	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—colon cancer	0.000593	0.00118	CbGpPWpGaD
L-Arginine—Decreased appetite—Methotrexate—colon cancer	0.000585	0.00426	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MYC—colon cancer	0.000579	0.00116	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TGFB1—colon cancer	0.000578	0.00115	CbGpPWpGaD
L-Arginine—Vomiting—Capecitabine—colon cancer	0.000575	0.00419	CcSEcCtD
L-Arginine—ASL—Metabolism—ABCB1—colon cancer	0.000574	0.00114	CbGpPWpGaD
L-Arginine—Rash—Capecitabine—colon cancer	0.00057	0.00416	CcSEcCtD
L-Arginine—Dermatitis—Capecitabine—colon cancer	0.00057	0.00415	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—CTNNB1—colon cancer	0.000567	0.00113	CbGpPWpGaD
L-Arginine—Headache—Capecitabine—colon cancer	0.000567	0.00413	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—colon cancer	0.000566	0.00113	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—colon cancer	0.000566	0.00113	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TYMS—colon cancer	0.000563	0.00112	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—TGFB1—colon cancer	0.000547	0.00109	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ODC1—colon cancer	0.000543	0.00108	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CHST5—colon cancer	0.000543	0.00108	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—SRC—colon cancer	0.000543	0.00108	CbGpPWpGaD
L-Arginine—Nausea—Capecitabine—colon cancer	0.000537	0.00391	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—colon cancer	0.000529	0.00105	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—colon cancer	0.000522	0.00104	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—SRC—colon cancer	0.000512	0.00102	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—colon cancer	0.000508	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—colon cancer	0.000499	0.000995	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—colon cancer	0.000496	0.00099	CbGpPWpGaD
L-Arginine—Hypersensitivity—Methotrexate—colon cancer	0.000496	0.00361	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—NRAS—colon cancer	0.000493	0.000983	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—colon cancer	0.000485	0.000967	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DLC1—colon cancer	0.000483	0.000963	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—colon cancer	0.000476	0.000949	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ABCB1—colon cancer	0.000475	0.000948	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TYMS—colon cancer	0.000467	0.000931	CbGpPWpGaD
L-Arginine—NOS3—Disease—AXIN2—colon cancer	0.000466	0.000929	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LGR5—colon cancer	0.000454	0.000905	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—colon cancer	0.000449	0.000896	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—colon cancer	0.000448	0.000894	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PPARG—colon cancer	0.000436	0.000871	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—EP300—colon cancer	0.000434	0.000866	CbGpPWpGaD
L-Arginine—Vomiting—Methotrexate—colon cancer	0.000428	0.00312	CcSEcCtD
L-Arginine—Rash—Methotrexate—colon cancer	0.000425	0.00309	CcSEcCtD
L-Arginine—Dermatitis—Methotrexate—colon cancer	0.000424	0.00309	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—KRAS—colon cancer	0.000424	0.000846	CbGpPWpGaD
L-Arginine—Headache—Methotrexate—colon cancer	0.000422	0.00307	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PIK3CA—colon cancer	0.000413	0.000824	CbGpPWpGaD
L-Arginine—Nausea—Methotrexate—colon cancer	0.0004	0.00291	CcSEcCtD
L-Arginine—ASL—Metabolism—PPARG—colon cancer	0.000399	0.000796	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PIK3CA—colon cancer	0.00039	0.000777	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—SRC—colon cancer	0.000389	0.000777	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—colon cancer	0.000382	0.000762	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—colon cancer	0.000381	0.000759	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—colon cancer	0.000361	0.000719	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000344	0.000685	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—colon cancer	0.000343	0.000685	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—colon cancer	0.000341	0.000681	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000338	0.000674	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—colon cancer	0.000337	0.000673	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PPARG—colon cancer	0.000331	0.00066	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ABCB1—colon cancer	0.000329	0.000657	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AXIN2—colon cancer	0.000326	0.00065	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TYMS—colon cancer	0.000324	0.000646	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—colon cancer	0.000322	0.000643	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—colon cancer	0.000318	0.000635	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—colon cancer	0.000314	0.000626	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—colon cancer	0.000311	0.00062	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—EP300—colon cancer	0.000286	0.00057	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—colon cancer	0.000274	0.000547	CbGpPWpGaD
L-Arginine—ASL—Metabolism—EP300—colon cancer	0.000261	0.000521	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—colon cancer	0.00026	0.000519	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000258	0.000515	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—colon cancer	0.000242	0.000483	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARG—colon cancer	0.000229	0.000457	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—EP300—colon cancer	0.000216	0.000432	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—colon cancer	0.000211	0.000421	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EP300—colon cancer	0.000207	0.000414	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—colon cancer	0.000202	0.000402	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—colon cancer	0.000196	0.000392	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—colon cancer	0.000194	0.000387	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—colon cancer	0.000193	0.000385	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—colon cancer	0.00018	0.00036	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—colon cancer	0.00018	0.00036	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR3—colon cancer	0.000173	0.000345	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—colon cancer	0.000173	0.000344	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—colon cancer	0.000167	0.000333	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EP300—colon cancer	0.000161	0.000321	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—colon cancer	0.00016	0.000319	CbGpPWpGaD
L-Arginine—NOS2—Disease—APC—colon cancer	0.000159	0.000317	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—colon cancer	0.000158	0.000315	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—colon cancer	0.000157	0.000312	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—colon cancer	0.000153	0.000306	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—colon cancer	0.000153	0.000304	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—colon cancer	0.000151	0.0003	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—EP300—colon cancer	0.00015	0.000299	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—colon cancer	0.000149	0.000298	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—colon cancer	0.000148	0.000296	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—colon cancer	0.000143	0.000286	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—colon cancer	0.000142	0.000283	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—colon cancer	0.000141	0.000281	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—colon cancer	0.00014	0.000279	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR3—colon cancer	0.000134	0.000268	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—colon cancer	0.000131	0.000261	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—colon cancer	0.00013	0.000259	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—colon cancer	0.000125	0.00025	CbGpPWpGaD
L-Arginine—NOS3—Disease—APC—colon cancer	0.000123	0.000246	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—colon cancer	0.000121	0.000241	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—colon cancer	0.000119	0.000238	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—colon cancer	0.000116	0.000231	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—colon cancer	0.000115	0.00023	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—colon cancer	0.000111	0.000221	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—colon cancer	0.00011	0.00022	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—colon cancer	0.000108	0.000215	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—colon cancer	0.000106	0.00021	CbGpPWpGaD
L-Arginine—NOS2—Disease—EP300—colon cancer	0.0001	0.0002	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARG—colon cancer	9.98e-05	0.000199	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—colon cancer	9.76e-05	0.000195	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—colon cancer	9.73e-05	0.000194	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR3—colon cancer	9.42e-05	0.000188	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—colon cancer	9.39e-05	0.000187	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—colon cancer	9.37e-05	0.000187	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—colon cancer	9.06e-05	0.000181	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—colon cancer	8.75e-05	0.000175	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—colon cancer	8.73e-05	0.000174	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APC—colon cancer	8.64e-05	0.000172	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—colon cancer	8.56e-05	0.000171	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—colon cancer	8.39e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—colon cancer	8.19e-05	0.000163	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—colon cancer	8.13e-05	0.000162	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—colon cancer	8.08e-05	0.000161	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—colon cancer	7.85e-05	0.000157	CbGpPWpGaD
L-Arginine—NOS3—Disease—EP300—colon cancer	7.8e-05	0.000156	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—colon cancer	7.58e-05	0.000151	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—colon cancer	7.43e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—colon cancer	7.29e-05	0.000145	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—colon cancer	6.87e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—colon cancer	6.79e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—colon cancer	6.78e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—colon cancer	6.64e-05	0.000133	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—EP300—colon cancer	6.53e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—colon cancer	6.28e-05	0.000125	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—colon cancer	6.09e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—colon cancer	6.07e-05	0.000121	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—colon cancer	5.93e-05	0.000118	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—colon cancer	5.87e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—colon cancer	5.77e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—colon cancer	5.74e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EP300—colon cancer	5.46e-05	0.000109	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—colon cancer	5.34e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—colon cancer	5.31e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—colon cancer	5.17e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—colon cancer	5.11e-05	0.000102	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—colon cancer	4.83e-05	9.63e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—colon cancer	4.76e-05	9.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—colon cancer	4.75e-05	9.47e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—colon cancer	4.71e-05	9.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—colon cancer	4.65e-05	9.28e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—colon cancer	4.4e-05	8.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—colon cancer	4.04e-05	8.06e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—colon cancer	3.95e-05	7.87e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—colon cancer	3.91e-05	7.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—colon cancer	3.74e-05	7.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—colon cancer	3.3e-05	6.58e-05	CbGpPWpGaD
